medigraphic.com
ISSN 2078-7162 (Print)

2020, Number 3

<< Back Next >>

Rev Cub de Med Fis y Rehab 2020; 12 (3)

Rehabilitation of respiratory sequelae in post-covid-19 patients with cerebrovascular disease

Bolaños AO, Seoane PJ, Bravo AT, Pérez PAE

Language: Spanish
References: 19
Page:
PDF size: 571.68 Kb.


ABSTRACT

The new coronavirus, which causes COVID-19, causes a severe acute respiratory syndrome. The rapid spread determined in March 2020 that it was a pandemic according to the World Health Organization. With a well organized health system, which implements preventive measures of isolation and disinfection, Cuba created action protocols for the treatment of COVID-19 and its convalescent state. Cerebrovascular disease is one of the neurological complications of COVID-19, associated to chronic respiratory disease, a sequel present in many of COVID-19 post-infection patients. The benefits of a respiratory rehabilitation program for patients with post-infection COVID-19 cerebrovascular disease need to be demonstrated. The objective of this article is to present a protocol for treating sequelae in COVID-19 carriers with cerebrovascular disease. An analysis of the different definitions elaborated by different authors for the individualized treatment of respiratory sequelae was made. For this purpose, it was carried out the review of the literature published from August to September in international databases, search strategy as controlled vocabulary. It is concluded that it is necessary to propose a personalized and comprehensive respiratory rehabilitation program aimed at respiratory and systemic recovery. A better quality of life of the patients and their social reintegration will be achieved with recommendations of the physical activity that they should do at home to maintain the results achieved in the program and its continuity.


REFERENCES

  1. Guo G, Ye L, Pan K, Chen Y, Xing D, Yan K, et al. New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention. Frontiers in cell and Developmental Biology. Molecular Medicine. 2020 [acceso: 25/08/2020]; 8(410). DOI: http://10.3389/fcell.2020.00410

  2. Protocolo de actuación nacional para la COVID-19 versión 1.5. [acceso: 02/09/2020]. Disponible en: http://www.sld.cu/anuncio/2020/05/11/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-covid19

  3. Conferencia de Prensa: Cuba frente a la COVID-19 [Archivo de video]. 3 septiembre 2020 [acceso: 3/09/2020] [25:47 min]. Disponible en: https://youtube.com/watch?v=IwIcXJIAtEs

  4. Tsivgoulis G, Palaiodimou L, Katsanos AH, Caso V, Köhrmann M, Molina C, et al. Neurological Manifestations and Implications of COVID-19 Pandemic. Ther Adv Neurol Disord. 2020 [acceso: 25/08/2020]; 13:1-14. DOI: http://doi.org/10.1177/17562

  5. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020 [acceso: 25/08/2020]; 94:809-10. DOI: http://10.1212/WNL.0000000000009455

  6. Armocida D, Pesce A, Raponi I, Pugliese F, Valentini V, Santoro A, Luigi Valentino Berra, MD, PhD. Letter: Anosmia in COVID-19: Severe Acute Respiratory Syndrome Coronavirus 2 Through the Nasoliary Epithelium and a Possible Spreading Way to the Central Nervous System-A Purpose to Study. Neurosurgery, August 2020 [acceso: 25/08/2020]; 87(2). DOI: https://doi.org/10.1093/neuros/nyaa204

  7. Brookes NRG, Fairley MW, Brookes GB. Acute Olfactory Dysfunction-A Primary Presentation of COVID-19 Infection. 2020 [acceso: 16/08/2020]; 1-5. DOI: http://10.1177/0145561320940119

  8. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic Alterations due to Respiratory Virus Infections. Front Cell Neurosci. 2018 [acceso: 26/08/2020]; 12:386 DOI: http://10.3389/fncel.2018.00386

  9. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression Profiling of ACE2, the Receptor of SARS-CoV-2. bioRxiv [preprint] 2020[acceso: 26/08/2020]; 1-13. DOI: http://10.1101/2020.01.26.919985

  10. Serra-Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay. 2020 [acceso: 25/08/2020]; 10(2). Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/846/1870

  11. OPS/OMS. Agenda de Salud Sostenible para las Américas 2018-2030. Objetivo 9: Enfermedades no transmisibles. Ginebra: OMS; 2020[acceso: 25/08/2020]. Disponible en: https://www.paho.org/es/agenda-salud-sostenible-para-americas-2018-2030/agenda-salud-sostenible-para-americas-2018-2030 6en:http://www.revfinlay.sld.cu/index.php/finlay/article/view/846

  12. Klok FA, Kruip MJHA, van der Meer NJM, Arbousd MS, Gommerse DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020. [acceso: 25/08/2020]. DOI: https://10.1016/j.thromres.2020.04.013

  13. Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, Karim AH and Sattar A Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front. Neurol. 2020 [acceso: 27/08/2020]; 11:518. DOI: https://10.3389/fneur.2020.00518

  14. Reddy ST, Garg T, Shah CH, Nascimento FA, Imrand R, Kanf P, et al. Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series Case Rep Neurol. 2020 [acceso: 27/08/2020]; 12:199-209. DOI: https://10.1159/000508958

  15. Letter to the editor. Rehabilitation of COVID-19 patients. J Rehabil Med 2020 [acceso: 27/08/2020]; 52. DOI: https://10.2340/16501977-2678

  16. Carda S, Invernizzi M , Bavikatte G , Bensmaïl D , Bianchi F, Deltombe T , et all. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Ann Phys Rehabil Med. 2020 [acceso: 27/08/2020]. DOI: https://doi.org/10.1016/j.rehab.2020.04.001

  17. Yang LL, Yang T. Pulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19). Chronic Diseases and Translational Medicine. May 2020 [acceso: 27/08/2020]; 6(2):79-86. DOI: https://10.1016/j.cdtm.2020.05.002

  18. Poussardin CH, Oulehri W, Eveisner M, Mertes PM, Colla O. In-ICU COVID-19 patients’ characteristics for an estimation in post-ICU rehabilitation care requirement. Anaesth Crit Care Pain Med. 2020 [acceso: 25/07/2020]. 39(4): 479-80. DOI: https://doi.org/10.1016/j.accpm.2020.06.002

  19. Polastri M, Nava S, Clini E, Vitacca M, Gosselink R. COVID-19 and pulmonary rehabilitation: preparing for phase three. European Respiratory Journal. 2020. DOI: https://doi.org/10.1183/13993003.01822-2020




2020     |     www.medigraphic.com